Activation of coagulation and fibrinolysis during cardiothoracic operations

Annals of Thoracic Surgery

Volumn 65, Issue 3, 1998, Pages 712-718

  Hunt, Beverley J ^a   Parratt, Rachel N ^a   Segal, Helen C ^a   Sheikh, Sajila ^a   Kallis, Panny ^a   Yacoub, Magdi ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEART SURGERY; HUMAN; HYPERCOAGULABILITY; MALE; OPEN HEART SURGERY; OPERATION DURATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THORAX SURGERY;

ADOLESCENT; ADULT; AGED; ANTITHROMBIN III; BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PLASMINOGEN; THORACIC SURGICAL PROCEDURES; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032033608     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01345-3     Document Type: Article

References (24)

1. Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of haemostasis during cardiopulmonary bypass evidence for thrombin mediated hyperfibrinolysis . Thromb Haemost. 68:1992;250-252.
2. Demeyer R. Coagulation in cardiac surgery. Curr Opin Anaesthesiol. 3:1990;77-85.
3. Bull MH, Huse WM, Bull BS. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anesthesiology. 43:1975;346-353.
4. Boisclair MD, Philippou H, Lane DA. Thrombogenic mechanisms in the human fresh insights obtained by immunodiagnostic studies of coagulation markers . Blood Coagul Fibrinolysis. 4:1993;1007-1021.
5. Boisclair MD, Lane DA, Philippou H, et al. Mechanism of thrombin generation during surgery and cardiopulmonary bypass. Blood. 82:1993;3350-3357.
6. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE. Studies on components of the plasma kallikrein-kinin system in patients undergoing cardiopulmonary bypass. Adv Exp Med Biol. 198b:1986;185-191.
7. Wachtfogel YT, Harpel PC, Edmunds LH, Colman RW. Formation of C1-C1-inhibitor, kallikrien-C1-inhibitor and plasmin-alpha 2-antiplasmin-inhibitor complexes during cardiopulmonary bypass. Blood. 73:1989;468-471.
8. Burman JF, Chung HI, Lane DA, Philippou H, Adami A, Lincoln JCR. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet. 344:1994;1192-1193.
9. Stibbe J, Kluft C, Brommer E, Gomes M, de Jong D, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest. 14:1984;375-382.
10. Gram J, Janetzko T, Jespersen J, Bruhn HD. Enhanced effective fibrinolysis following the neutralisation of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost. 63:1990;241-245.
11. Havel M, Teufelsbauer H, Knobl Dalmatiner R, et al. The effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg. 101:1991;968-972.
12. Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 108:1994;1083-1091.
13. Davis R, Whittington R. Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs. 49:1995;954-983.
14. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth. 3:1989;181-188.
15. Macfarlane RG. Fibrinolysis following operation. Lancet. I:1937;10-12.
16. Mackie I, Machin S. Fibrinolysis. Chanarin I. Laboratory haematology. 1989;362-363 Churchill Livingstone, London.
17. Kuitunen A, Hynynen M, Salmenpera M, et al. Anaesthesia affects plasma concentrations of vasopressin, von Willebrand factor and coagulation factor VIII in cardiac surgical patients. Br J Anaesth. 70:1993;173-180.
18. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds H. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation. 93:1996;2014-2018.
19. Chandler WL, Fitch JCK, Wall MH, et al. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost. 74:1995;1293-1297.
20. Valen G, Eriksson E, Risberg B, Vaage J. Fibrinolysis during cardiac surgery. Eur J Cardiothorac Surg. 8:1994;324-330.
21. Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on platelet glycoprotein 1b-von Willebrand factor interactions. Blood. 65:1985;32-40.
22. Hong SY, Yang DH, Kim PN. Urokinase concentration in the renal artery and vein. Nephron. 61:1992;176-180.
23. Spannagl M, Dooijewaard G, Dietrich W, Kluft C. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass. Thromb Haemost. 73:1995;825-828.
24. Mannucci L, Gerometta PS, Mussoni L, et al. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Thromb Haemost. 73:1995;356-361.